Hong WK - Search Results

1

Phase II trial of carboplatin plus cisplatin in recurrent and advanced squamous cell carcinoma of the head and neck.

Dimery IW, Brooks BJ, Winn R, Martin T, Shirinian M, Hong WK. Dimery IW, et al. Among authors: hong wk. J Clin Oncol. 1991 Nov;9(11):1939-44. doi: 10.1200/JCO.1991.9.11.1939. J Clin Oncol. 1991. PMID: 1941052 Clinical Trial.

2

Phase II clinical trial of 4'-O-tetrahydropyranyl-adriamycin (THP-adriamycin) in recurrent squamous cell carcinoma of the head and neck.

Shin DM, Kramer AM, Dimery IW, Raber MN, Ewer M, Hong WK. Shin DM, et al. Among authors: hong wk. Invest New Drugs. 1991 Feb;9(1):89-91. doi: 10.1007/BF00194554. Invest New Drugs. 1991. PMID: 2026488 Clinical Trial.

3

Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma.

Dimery IW, Legha SS, Shirinian M, Hong WK. Dimery IW, et al. Among authors: hong wk. J Clin Oncol. 1990 Jun;8(6):1056-62. doi: 10.1200/JCO.1990.8.6.1056. J Clin Oncol. 1990. PMID: 2112183 Clinical Trial.

4

Neoadjuvant chemotherapy and radiotherapy in larynx preservation.

Dimery IW, Kramer AM, Choksi AJ, Hong WK. Dimery IW, et al. Among authors: hong wk. Am J Clin Oncol. 1989 Apr;12(2):173-7. doi: 10.1097/00000421-198904000-00017. Am J Clin Oncol. 1989. PMID: 2468283 Review. No abstract available.

5

Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Paredes J, Hong WK, Felder TB, Dimery IW, Choksi AJ, Newman RA, Castellanos AM, Robbins KT, McCarthy K, Atkinson N, et al. Paredes J, et al. Among authors: hong wk. J Clin Oncol. 1988 Jun;6(6):955-62. doi: 10.1200/JCO.1988.6.6.955. J Clin Oncol. 1988. PMID: 2836565 Clinical Trial.

6

Adjuvant chemotherapy of head and neck cancer: the past, the present, and the future.

Choksi AJ, Dimery IW, Hong WK. Choksi AJ, et al. Among authors: hong wk. Semin Oncol. 1988 Jun;15(3 Suppl 3):45-59. Semin Oncol. 1988. PMID: 3293216 Review.

7

Continuous cisplatin (24-hour) and 5-fluorouracil (120-hour) infusion in recurrent head and neck squamous cell carcinoma.

Choksi AJ, Hong WK, Dimery IW, James P, Guillamondegui OM, Byers RM. Choksi AJ, et al. Among authors: hong wk. Cancer. 1988 Mar 1;61(5):909-12. doi: 10.1002/1097-0142(19880301)61:5<909::aid-cncr2820610509>3.0.co;2-3. Cancer. 1988. PMID: 3338056

8

Phase II study of carboplatin and continuous infusion bleomycin followed by cisplatin and 5-fluorouracil in recurrent head and neck cancer.

Huber MH, Lippman SM, Benner SE, Shirinian M, Dimery IW, Earley CL, Winn RJ, Brooks J, Baez L, Hong WK. Huber MH, et al. Among authors: hong wk. Ann Oncol. 1995 Jan;6(1):83-5. doi: 10.1093/oxfordjournals.annonc.a059054. Ann Oncol. 1995. PMID: 7536031 Free article. Clinical Trial.

9

Phase II study of carboplatin and edatrexate (10-EdAM) with leucovorin rescue for patients with recurrent squamous cell carcinoma of the head and neck.

Huber MH, Dimery IW, Benner SE, Lippman SM, Shirinian M, Esparaz B, Frenning D, Guillory-Perez C, Hong WK. Huber MH, et al. Among authors: hong wk. Invest New Drugs. 1994;12(4):327-31. doi: 10.1007/BF00873049. Invest New Drugs. 1994. PMID: 7775135 Clinical Trial.

10

Phase I/II study of cisplatin, 5-fluorouracil and alpha-interferon for recurrent carcinoma of the head and neck.

Huber MH, Shirinian M, Lippman SM, Dimery IW, Frankenthaler RA, Hong WK. Huber MH, et al. Among authors: hong wk. Invest New Drugs. 1994;12(3):223-9. doi: 10.1007/BF00873963. Invest New Drugs. 1994. PMID: 7896541 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

761 results

Search Page

Filters